VERTEX PHARMACEUTICALS INCORPORATED Quotes Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 394.3 USD | +0.20% |
|
-0.57% | -3.10% |
| Apr. 18 | Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain | MT |
| Apr. 17 | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-15 | 2024-04-16 | 2024-04-17 | 2024-04-18 | 2024-04-19 | |
|---|---|---|---|---|---|
| Last | 397.36 $ | 394.17 $ | 393.1 $ | 393.48 $ | 394.3 $ |
| Volume | 1 373 702 | 695 469 | 881 020 | 949 091 | 1 272 738 |
| Change | +0.20% | -0.80% | -0.27% | +0.10% | +0.20% |
| Opening | 400.00 | 396.88 | 394.94 | 394.19 | 394.7 |
| High | 402.49 | 398.49 | 398.11 | 396.14 | 397 |
| Low | 396.69 | 392.81 | 392.03 | 391.01 | 391.2 |
Performance
| 1 day | +0.83% | ||
| 1 week | -0.25% | ||
| Current month | -5.37% | ||
| 1 month | -4.73% | ||
| 3 months | -9.07% | ||
| 6 months | +8.43% | ||
| Current year | -2.78% | ||
| 1 year | +20.43% | ||
| 3 years | +80.47% | ||
| 5 years | +134.73% | ||
| 10 years | +504.19% |
Volumes
marketsDaily volume
156 962
Estimated daily volume
1 841 058
Avg. Volume 20 sessions
923 826
Daily volume ratio
1.99
Avg. Volume 20 sessions USD
366 532 584.63
Record volume 1
42 258 300
Record volume 2
40 221 040
Record volume 3
25 236 840
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
101 698 582 283
Net sales (USD)
9 869 200 000
Number of employees
5 400
Sales / Employee (USD)
1 827 630
Free-Float
99.89 %
Free-Float capitalization (USD)
101 584 105 179
Average Daily Capital Traded
0.36%
Highs and lows
1 week
391.01
402.49
1 month
391.01421.45
Current year
391.01448.40
1 year
316.43448.40
3 years
176.36448.40
5 years
164.07448.40
10 years
62.41448.40
Indicators
Moving average 5 days
394.93
Moving average 20 days
407.52
Moving average 50 days
414.67
Moving average 100 days
408.70
Price spread / (MMA5)
-0.46%
Price spread / (MMA20)
+2.71%
Price spread / (MMA50)
+4.52%
Price spread / (MMA100)
+3.01%
STIM
RSI 9 days
26.42
RSI 14 days
31.83
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.83% | -0.25% | -2.78% | +20.43% | 102B | ||
| +0.69% | -0.54% | +2.45% | +11.24% | 96.07B | ||
| -0.82% | -3.77% | -1.25% | -1.60% | 21.66B | ||
| +1.64% | -0.01% | -18.07% | -29.00% | 20.77B | ||
| +0.45% | -3.36% | -7.31% | -27.91% | 18.53B | ||
| +0.65% | -0.84% | -40.31% | -46.26% | 16.91B | ||
| -1.73% | -8.41% | -28.25% | -49.94% | 13.79B | ||
| -0.42% | -1.57% | +0.60% | +26.39% | 13.33B | ||
| -0.24% | -4.81% | +21.29% | -5.77% | 10.94B | ||
| -0.47% | -11.17% | -21.87% | -24.78% | 8.57B | ||
| +1.75% | -2.15% | +13.46% | +72.11% | 8.05B | ||
| 0.00% | +0.57% | -0.73% | +57.94% | 7.65B | ||
| -0.55% | -5.43% | +248.71% | +205.10% | 7.13B | ||
| -4.68% | -9.21% | -57.36% | -76.43% | 7.05B | ||
| -0.72% | -6.34% | -19.73% | +76.69% | 7.02B | ||
| +0.13% | -0.79% | -5.67% | +18.11% | 6.63B | ||
| Average | -0.14% | -4.63% | +5.20% | +14.14% | ||
| Weighted average by Cap. | +0.38% | -3.16% | -0.84% | +8.79% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
446540df8e99b153eb201827a.uAzuaM6TvCqmR4IM44eQh8Dn2YaR5nv1OLGBhZXvonQ.ij6-Xpfr712VMPpf0fDY85jRveuj1AO9bsHM__aJ5THUWMMdoqL4ZpYP4Q
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:03:07 am | 395.8 | 100 | 117,649 |
| 10:02:44 am | 395.5 | 100 | 117,549 |
| 10:02:16 am | 395.9 | 100 | 117,449 |
| 10:02:16 am | 395.7 | 100 | 117,349 |
| 10:02:01 am | 395.7 | 100 | 117,249 |
| 10:01:57 am | 395.7 | 100 | 117,149 |
| 10:01:50 am | 395.7 | 100 | 117,049 |
| 10:00:28 am | 395.6 | 200 | 116,949 |
| 10:00:28 am | 395.8 | 100 | 116,749 |
| 10:00:28 am | 395.8 | 100 | 116,649 |
Monthly variations
Annual change
| 2024 | -3.30% | ||
| 2023 | +40.90% | ||
| 2022 | +31.50% | ||
| 2021 | -7.08% | ||
| 2020 | +7.94% | ||
| 2019 | +32.13% | ||
| 2018 | +10.58% | ||
| 2017 | +103.42% | ||
| 2016 | -41.45% | ||
| 2015 | +5.92% | ||
| 2014 | +59.89% | ||
| 2013 | +77.33% | ||
| 2012 | +26.17% | ||
| 2011 | -5.20% | ||
| 2010 | -18.25% | ||
| 2009 | +41.05% | ||
| 2008 | +30.78% | ||
| 2007 | -37.92% | ||
| 2006 | +35.24% | ||
| 2005 | +161.78% | ||
| 2004 | +2.13% | ||
| 2003 | -34.70% | ||
| 2002 | -35.54% | ||
| 2001 | -65.61% | ||
| 2000 | +308.57% | ||
| 1999 | +17.65% | ||
| 1998 | -9.85% | ||
| 1997 | -18.01% | ||
| 1996 | +51.89% | ||
| 1995 | +76.67% | ||
| 1994 | -18.92% | ||
| 1993 | +89.74% | ||
| 1992 | -33.90% | ||
| 1991 | +63.89% |
- Stock Market
- Equities
- VRTX Stock
- Quotes Vertex Pharmaceuticals Incorporated
